3ehb:D (ILE2) to (ILE107) A D-PATHWAY MUTATION DECOUPLES THE PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE BY ALTERING THE SIDE CHAIN ORIENTATION OF A DISTANT, CONSERVED GLUTAMATE | PROTON PUMPING, WATER CHAIN, ELECTRON TRANSFER, CELL INNER MEMBRANE, CELL MEMBRANE, COPPER, ELECTRON TRANSPORT, HEME, HYDROGEN ION TRANSPORT, ION TRANSPORT, IRON, MEMBRANE, METAL-BINDING, OXIDOREDUCTASE, RESPIRATORY CHAIN, TRANSMEMBRANE, TRANSPORT, PYRROLIDONE CARBOXYLIC ACID, OXIDOREDUCTASE/IMMUNE SYSTEM COMPLEX
4x9h:B (PHE105) to (LEU197) CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 8.4, N-TERMINAL FOUR IG DOMAINS | IG FOLD, CELL ADHESION
3sdy:L (GLU1) to (GLU105) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4i18:B (ILE3) to (THR112) CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT | IMMUNOGLOBULIN FOLD, PROLACTIN BINDING, RECEPTOR SIGNALING, CYTOKINE, SIGNALING PROTEIN
4i2x:E (GLU3) to (SER119) CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117 | PROTEIN-FAB COMPLEX, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, SIGNAL REGULATORY PROTEIN, CD47, CELL SURFACE, IMMUNE SYSTEM
3fn0:L (GLU3) to (ILE106) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB Z13E1 IN COMPLEX WITH A 12-RESIDUE PEPTIDE CONTAINING THE Z13E1 EPITOPE ON GP41 | Z13E1, Z13, HIV, ENV, GP41, IMMUNE SYSTEM
2dm2:A (ALA8) to (GLN101) SOLUTION STRUCTURE OF THE FIRST IG DOMAIN OF HUMAN PALLADIN | BETA-SANDWICH, KIAA0992, MYOPALLADIN, ACTIN-ASSOCIATED SCAFFOLD, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, PROTEIN BINDING
1q72:L (ILE2) to (ALA109) ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE | ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM
1qbl:L (ASP1) to (ILE106) FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION | IMMUNOGLOBULIN, IGG1 KAPPA, ANTIBODY, FAB FRAGMENT, ANTI- CYTOCHROME C ANTIBODY
2uv3:A (GLU3) to (LYS116) STRUCTURE OF THE SIGNAL-REGULATORY PROTEIN (SIRP) ALPHA DOMAIN THAT BINDS CD47. | CD47-BINDING DOMAIN OF SIRP-ALPHA, RECEPTOR, MEMBRANE, SH3- BINDING, GLYCOPROTEIN, TRANSMEMBRANE, PHOSPHORYLATION, HUMAN SIRP-ALPHA N TERMINAL V DOMAIN, IMMUNOGLOBULIN DOMAIN, SIGNAL-REGULATORY PROTEIN ALPHA
2uv3:B (GLU3) to (LYS116) STRUCTURE OF THE SIGNAL-REGULATORY PROTEIN (SIRP) ALPHA DOMAIN THAT BINDS CD47. | CD47-BINDING DOMAIN OF SIRP-ALPHA, RECEPTOR, MEMBRANE, SH3- BINDING, GLYCOPROTEIN, TRANSMEMBRANE, PHOSPHORYLATION, HUMAN SIRP-ALPHA N TERMINAL V DOMAIN, IMMUNOGLOBULIN DOMAIN, SIGNAL-REGULATORY PROTEIN ALPHA
2edk:A (PRO8) to (GLU99) SOLUTION STRUCTURE OF THE THIRD IG-LIKE DOMAIN FROM HUMAN MYOSIN-BINDING PROTEIN C, FAST-TYPE | IG FOLD, FAST MYBP-C, C-PROTEIN, SKELETAL MUSCLE FAST- ISOFORM, MYBPCF, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, CONTRACTILE PROTEIN
2uyl:A (VAL3) to (ALA114) CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1 | FAB FRAGMENT, MONOCLONAL ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, ANTI-LPS VIBRIO CHOLERAE
2uyl:M (GLU1) to (ALA114) CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1 | FAB FRAGMENT, MONOCLONAL ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, ANTI-LPS VIBRIO CHOLERAE
2uyl:X (GLU1) to (ALA114) CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1 | FAB FRAGMENT, MONOCLONAL ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, ANTI-LPS VIBRIO CHOLERAE
1fh5:L (ILE3) to (LEU107) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MONOCLONAL ANTIBODY MAK33 | FAB, BIP, IMMUNE SYSTEM
1seq:L (ILE2) to (ILE106) FAB MNAC13 | IMMUNOGLOBULIN, IMMUNE SYSTEM
4lly:B (ILE2) to (GLY108) CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE AND CONSTANT DOMAIN REDESIGNS (VRD2 AND CRD2) AT 1.6A | FAB, IMMUNE SYSTEM
4lri:A (ASP1) to (THR114) ANTI CMV FAB FRAGMENT | FAB FRAGMENT, CMV NEUTRALIZING ANTIBODY, GLYCOPROTEIN H OR GH FROM CMV, IMMUNE SYSTEM
4lvn:B (ASP1) to (LEU107) CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX | ALPHA BETA, ENZYME-PRODOMAIN COMPLEX, ROSSMANN FOLD, SERINE PROTEASE, CALCIUM IONS, PRODOMAIN, PARASITOPHOROUS VACUOLE, HYDROLASE- INHIBITOR-IMMUNE SYSTEM COMPLEX
2hvj:B (ASP1) to (ALA109) CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+ | POTASSIUM CHANNEL, MEMBRANE PROTEIN, TETRABUTYLAMMONIUM, K+, KCSA
1iai:M (ILE2) to (ILE107) IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX | COMPLEX (IMMUNOGLOBULIN IGG1/IGG2A)
5aam:B (ILE134) to (ILE242) STRUCTURE OF A REDESIGNED CROSS-REACTIVE ANTIBODY TO DENGUE VIRUS WITH INCREASED IN VIVO POTENCY | IMMUNE SYSTEM, SCFV DENGUE ANTIBODY ENVELOPE DOMAIN III
5aaw:K (ILE134) to (ILE242) STRUCTURE OF A REDESIGNED CROSS-REACTIVE ANTIBODY TO DENGUE VIRUS WITH INCREASED IN VIVO POTENCY | VIRAL PROTEIN, SCFV DENGUE ANTIBODY ENVELOPE DOMAIN III
1jrh:L (VAL2) to (ALA109) COMPLEX (ANTIBODY/ANTIGEN) | CYTOKINE RECEPTOR, COMPLEX (ANTIBODY/ANTIGEN), TRANSMEMBRANE, GLYCOPROTEIN
2jju:B (GLU3) to (VAL114) STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) BETA | IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN SUPERFAMILY, SIGNAL REGULATORY PROTEIN BETA, IMMUNE SYSTEM, TRANSMEMBRANE, PAIRED RECEPTOR, ALTERNATIVE SPLICING, SIRP, SIRPB1, MEMBRANE, POLYMORPHISM, GLYCOPROTEIN
2jjv:A (GLU3) to (SER113) STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) BETA(2) | IMMUNE SYSTEM, IMMUNOGLOBULIN SUPERFAMILY, SIGNAL REGULATORY PROTEIN BETA, SIRP, SIRPB2, PAIRED RECEPTOR
1wej:L (ASP1) to (ILE106) IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION | IMMUNOGLOBULIN, IGG1 KAPPA, FAB FRAGMENT, HORSE CYTOCHROME C, COMPLEX (ANTIBODY/ELECTRON TRANSPORT)
4nry:L (GLN3) to (THR109) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 | IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM
1mhp:L (ILE2) to (ILE105) CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY | INTEGRIN, CELL ADHESION, RECEPTOR, ANTIBODY, IMMUNE SYSTEM
1mhp:Y (ILE2) to (ILE105) CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY | INTEGRIN, CELL ADHESION, RECEPTOR, ANTIBODY, IMMUNE SYSTEM
4aeh:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY | IMMUNE SYSTEM, ANDROCTONUS, ALPHA-TOXIN, COMBINING SITE, EPITOPE, PHARMACOLOGICAL SITE, VENOM, VOLTAGE- ACTIVATED SODIUM CHANNEL, SCORPION
5d1z:C (GLN4) to (THR110) ISDB NEAT1 BOUND BY CLONE D4-10 | ISDB, NEAT1, GERMLINE ENCODED, IMMUNE SYSTEM
5d1z:H (GLN5) to (ILE108) ISDB NEAT1 BOUND BY CLONE D4-10 | ISDB, NEAT1, GERMLINE ENCODED, IMMUNE SYSTEM
35c8:L (VAL3) to (ILE106) CATALYTIC ANTIBODY 5C8, FAB-INHIBITOR COMPLEX | CATALYTIC ANTIBODY, FAB, RING CLOSURE REACTION
3b5h:A (PRO104) to (ARG203) CRYSTAL STRUCTURE OF THE EXTRACELLULAR PORTION OF HAB18G/CD147 | IG-LIKE DOMAIN, CELL INVASION
3bkm:L (ASP1) to (GLU105) STRUCTURE OF ANTI-AMYLOID-BETA FAB WO2 (FORM A, P212121) | ABETA, AMYLOID BETA PEPTIDE, FAB, WO2, ALZHEIMER'S DISEASE, IMMUNOTHERAPIES, APP, IMMUNE SYSTEM
4r8w:L (GLU1) to (ILE107) CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A NEUTRALIZING ANTIBODY CT149 | INFLUENZA A VIRUS, HEMAGGLUTININ, NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
5i17:L (GLU1) to (ILE107) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-20 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i8e:B (ILE2) to (ILE106) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING HIV-1 FUSION PEPTIDE- TARGETING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
5i8e:D (ILE2) to (ILE106) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING HIV-1 FUSION PEPTIDE- TARGETING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
5ibu:L (GLU1) to (ILE107) 6652 FAB (UNBOUND) | ANTIBODY, INFLUENZA, UNBOUND, IMMUNE SYSTEM
3q1s:L (GLU3) to (ILE106) HIV-1 NEUTRALIZING ANTIBODY Z13E1 IN COMPLEX WITH EPITOPE DISPLAY PROTEIN | IMMUNOGLOBULIN FOLD, ANTIBODY, GP41, IMMUNE SYSTEM-CYTOKINE COMPLEX
4f37:L (ILE2) to (GLU110) STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER'S DISEASE A PEPTIDE | AMYLOID-BETA, ALZHEIMER'S DISEASE, IMMUNE SYSTEM
3qpq:L (ASP1) to (LEU106) CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, TLR-3
3qpq:I (ASP1) to (THR110) CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, TLR-3
4gay:L (ILE2) to (ALA109) STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 | ANTIBODY FAB, NEUTRALIZING ANTIBODY, HCV E2, IMMUNE SYSTEM
4gjt:C (GLY1) to (ARG109) COMPLEX STRUCTURE OF NECTIN-4 BOUND TO MV-H | SIX-BLADED -PROPELLER, IGV-LIKE FOLD, VIRAL ENTRY, MV-H, NECTIN-4, BETA4/BETA5 GROOVE, MEMBRANE PROTEIN-VIRAL PROTEIN COMPLEX
4hh8:A (PRO2) to (LEU118) CRYSTAL STRUCTURE OF BOVINE BUTYROPHILIN | IMMUNOGLOBULIN FOLD, MILK FAT GLOBULE, PROTEIN BINDING
4llu:B (ILE2) to (GLY108) STRUCTURE OF PERTUZUMAB FAB WITH LIGHT CHAIN CLAMBDA AT 2.16A | FAB, IMMUNE SYSTEM
1l7i:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4 | IG DOMAIN, FAB FRAGMENT, IMMUNE SYSTEM
3axl:A (GLN3) to (GLN120) MURINE VALPHA 10 VBETA 8.1 T-CELL RECEPTOR | IMMUNOGLOBULIN FOLD, T-CELL RECEPTOR, CD1D BINDING, IMMUNE SYSTEM
3bd3:A (LEU160) to (ILE270) CRYSTAL STRUCTURE OF SINGLE DOMAIN VL OF AN ANTI-DNA BINDING ANTIBODY 3D8 SCFV AND ITS ACTIVE SITE REVEALED BY COMPLEX STRUCTURES OF A SMALL MOLECULE AND METALS | 3D8, CATALYTIC ANTIBODY, ANTI-DNA, IMMUNE SYSTEM
4s1r:L (VAL3) to (LYS109) CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY, 45-VRC01.H08.F-117225, IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE | HIV-1, NEUTRALIZING ANTIBODIES, VRC01-LINEAGE, ANTIBODY MATURATION, EVOLUTIONARY RATE, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX